CN106491886A - 一种用于皮肤瘙痒的药物组合物及其制备方法 - Google Patents
一种用于皮肤瘙痒的药物组合物及其制备方法 Download PDFInfo
- Publication number
- CN106491886A CN106491886A CN201611093839.XA CN201611093839A CN106491886A CN 106491886 A CN106491886 A CN 106491886A CN 201611093839 A CN201611093839 A CN 201611093839A CN 106491886 A CN106491886 A CN 106491886A
- Authority
- CN
- China
- Prior art keywords
- parts
- pharmaceutical composition
- skin pruritus
- chloromycetin
- spironolactone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
- A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/36—Skin; Hair; Nails; Sebaceous glands; Cerumen; Epidermis; Epithelial cells; Keratinocytes; Langerhans cells; Ectodermal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Developmental Biology & Embryology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明公开了一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌2‑5份、四环素5‑12份、牛磺酸5‑8份、氯霉素1‑4份、血蝎提取物2‑6份、甲硝唑4‑9份、血余炭0.5‑3份、氧氟沙星3‑5份、扑尔敏4‑8份、麻黄碱1‑4份和螺内酯4‑8份。本发明还公布了该药物的制备方法。本发明原料来源广泛,制备工艺简单,生产成本低,适用于大规模的工业化生产;本发明制备的药物只需喷洒在瘙痒处,使用简单方便,具有杀菌、快速止痒和消炎的功能,对于荨麻疹、过敏性皮炎等常见皮肤病有良好的治疗效果。
Description
技术领域
本发明涉及一种药物,具体是一种用于皮肤瘙痒的药物组合物。
背景技术
随着各种污染问题的加重,人们面临各种各样疾病的威胁,皮肤病就是其中一种。皮肤病是发生在皮肤和皮肤附属器官疾病的总称。皮肤是人体最大的器官,皮肤病的种类不但繁多,多种内脏发生的疾病也可以在皮肤上有表现,引起皮肤病的原因很多,比如感染因素引起的皮肤病,如麻风、疥疮、真菌病、皮肤细菌感染等常常有一定的传染性,不但影响身体健康,而且引起恐慌与社会歧视,其他引起皮肤病的内外在因素,如机械性、物理性、化学性、生物性、内分泌性、免疫性等。皮肤病最多发的症状是瘙痒感,常见于湿疹、荨麻疹、神经性皮炎、扁平苔藓、外阴肛门部瘙痒等。目前治疗皮肤瘙痒的药物比较多,虽然具有一定的缓解作用,但大多存在效果差的问题,这就不利于皮肤病患者的康复。
发明内容
本发明的目的在于提供一种用于皮肤瘙痒的药物组合物,以解决上述背景技术中提出的问题。
为实现上述目的,本发明提供如下技术方案:
一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌2-5份、四环素5-12份、牛磺酸5-8份、氯霉素1-4份、血蝎提取物2-6份、甲硝唑4-9份、血余炭0.5-3份、氧氟沙星3-5份、扑尔敏4-8份、麻黄碱1-4份和螺内酯4-8份。
作为本发明进一步的方案:所述用于皮肤瘙痒的药物组合物由以下原料按照重量份组成:乳酸菌3-5份、四环素7-12份、牛磺酸6-8份、氯霉素2-4份、血蝎提取物3-6份、甲硝唑6-9份、血余炭1.5-3份、氧氟沙星3.5-5份、扑尔敏6-8份、麻黄碱2-4份和螺内酯5-8份。
作为本发明进一步的方案:所述用于皮肤瘙痒的药物组合物由以下原料按照重量份组成:乳酸菌4份、四环素10份、牛磺酸7份、氯霉素3份、血蝎提取物5份、甲硝唑8份、血余炭2份、氧氟沙星4.5份、扑尔敏7份、麻黄碱3份和螺内酯7份。
所述用于皮肤瘙痒的药物组合物的制备方法,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重3-7倍的生理盐水,搅拌机在常温下以240-400rpm的转速搅拌25-50分钟,即可得到成品。
与现有技术相比,本发明的有益效果是:本发明原料来源广泛,制备工艺简单,生产成本低,适用于大规模的工业化生产;本发明制备的药物只需喷洒在瘙痒处,使用简单方便,具有杀菌、快速止痒和消炎的功能,对于荨麻疹、过敏性皮炎等常见皮肤病有良好的治疗效果。
具体实施方式
下面结合具体实施方式对本专利的技术方案作进一步详细地说明。
实施例1
一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌2份、四环素5份、牛磺酸5份、氯霉素1份、血蝎提取物2份、甲硝唑4份、血余炭0.5份、氧氟沙星3份、扑尔敏4份、麻黄碱1份和螺内酯4份。
所述用于皮肤瘙痒的药物组合物的制备方法,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重4倍的生理盐水,搅拌机在常温下以240rpm的转速搅拌28分钟,即可得到成品。
实施例2
一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌3份、四环素7份、牛磺酸6份、氯霉素2份、血蝎提取物3份、甲硝唑6份、血余炭1.5份、氧氟沙星3.5份、扑尔敏6份、麻黄碱2份和螺内酯5份。
所述用于皮肤瘙痒的药物组合物的制备方法,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重6倍的生理盐水,搅拌机在常温下以320rpm的转速搅拌35分钟,即可得到成品。
实施例3
一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌4份、四环素10份、牛磺酸7份、氯霉素3份、血蝎提取物5份、甲硝唑8份、血余炭2份、氧氟沙星4.5份、扑尔敏7份、麻黄碱3份和螺内酯7份。
所述用于皮肤瘙痒的药物组合物的制备方法,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重4倍的生理盐水,搅拌机在常温下以360rpm的转速搅拌40分钟,即可得到成品。
实施例4
一种用于皮肤瘙痒的药物组合物,由以下原料按照重量份组成:乳酸菌5份、四环素12份、牛磺酸8份、氯霉素4份、血蝎提取物6份、甲硝唑9份、血余炭3份、氧氟沙星5份、扑尔敏8份、麻黄碱4份和螺内酯8份。
所述用于皮肤瘙痒的药物组合物的制备方法,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重5倍的生理盐水,搅拌机在常温下以400rpm的转速搅拌35分钟,即可得到成品。
对不同症状的病人采用实施例1-4的产品,典型病例如下:
病例一,李某,女,28岁。患有肛门湿疹两年,瘙痒以夜间最为明显,两年期间采用外用药物均无效,用手抓会有出血和疼痛症状出血。采用实施例1的产品,一周后,肛门湿疹痊愈。
病例二,王某,男,18岁。两个月之前全身出现小丘疹,奇痒难耐,经医院诊断为荨麻疹,采用实施例2的产品,4天后痊愈。
病例三,邵某,女,38岁。一周前出现面部红斑瘙痒,瘙痒难耐,经医院诊断为过敏性皮炎,采用实施例3的产品,2天后痊愈。
病例四,黄某,男,4岁。四天前身体上一块一块的红肿并且皮肤瘙痒,经医院诊断为湿疹,采用实施例4的产品,2天后痊愈。
从上述病例可以看出,本发明制备的产品对于荨麻疹、过敏性皮炎等症状引起的皮肤瘙痒具有良好的治疗效果。
对于本领域技术人员而言,显然本发明不限于上述示范性实施例的细节,而且在不背离本发明的精神或基本特征的情况下,能够以其他的具体形式实现本发明。因此,无论从哪一点来看,均应将实施例看作是示范性的,而且是非限制性的,本发明的范围由所附权利要求而不是上述说明限定,因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外,应当理解,虽然本说明书按照实施方式加以描述,但并非每个实施方式仅包含一个独立的技术方案,说明书的这种叙述方式仅仅是为清楚起见,本领域技术人员应当将说明书作为一个整体,各实施例中的技术方案也可以经适当组合,形成本领域技术人员可以理解的其他实施方式。
Claims (4)
1.一种用于皮肤瘙痒的药物组合物,其特征在于,由以下原料按照重量份组成:乳酸菌2-5份、四环素5-12份、牛磺酸5-8份、氯霉素1-4份、血蝎提取物2-6份、甲硝唑4-9份、血余炭0.5-3份、氧氟沙星3-5份、扑尔敏4-8份、麻黄碱1-4份和螺内酯4-8份。
2.根据权利要求1所述的用于皮肤瘙痒的药物组合物,其特征在于,由以下原料按照重量份组成:乳酸菌3-5份、四环素7-12份、牛磺酸6-8份、氯霉素2-4份、血蝎提取物3-6份、甲硝唑6-9份、血余炭1.5-3份、氧氟沙星3.5-5份、扑尔敏6-8份、麻黄碱2-4份和螺内酯5-8份。
3.根据权利要求1所述的用于皮肤瘙痒的药物组合物,其特征在于,由以下原料按照重量份组成:乳酸菌4份、四环素10份、牛磺酸7份、氯霉素3份、血蝎提取物5份、甲硝唑8份、血余炭2份、氧氟沙星4.5份、扑尔敏7份、麻黄碱3份和螺内酯7份。
4.一种如权利要求1-3任一所述的用于皮肤瘙痒的药物组合物的制备方法,其特征在于,具体步骤如下:
步骤一,按照重量份称取各种原料,备用;
步骤二,将乳酸菌、四环素、牛磺酸、氯霉素、血蝎提取物、甲硝唑、血余炭、氧氟沙星、扑尔敏、麻黄碱和螺内酯放入搅拌机中并且添加混合物总重3-7倍的生理盐水,搅拌机在常温下以240-400rpm的转速搅拌25-50分钟,即可得到成品。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611093839.XA CN106491886A (zh) | 2016-12-02 | 2016-12-02 | 一种用于皮肤瘙痒的药物组合物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611093839.XA CN106491886A (zh) | 2016-12-02 | 2016-12-02 | 一种用于皮肤瘙痒的药物组合物及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106491886A true CN106491886A (zh) | 2017-03-15 |
Family
ID=58330307
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611093839.XA Withdrawn CN106491886A (zh) | 2016-12-02 | 2016-12-02 | 一种用于皮肤瘙痒的药物组合物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106491886A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3735258A4 (en) * | 2018-01-02 | 2021-10-13 | Skinkick, Llc | TOPICAL SKIN CARE COMPOSITIONS |
-
2016
- 2016-12-02 CN CN201611093839.XA patent/CN106491886A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3735258A4 (en) * | 2018-01-02 | 2021-10-13 | Skinkick, Llc | TOPICAL SKIN CARE COMPOSITIONS |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102327478A (zh) | 一种治疗烧烫伤的药物组合物及其制备方法 | |
CN107050063A (zh) | 治疗过敏体质的乳酸菌组合物及其制备方法 | |
CN102357164B (zh) | 一种临床护理烧伤的药物组合物及其制备方法 | |
CN106491886A (zh) | 一种用于皮肤瘙痒的药物组合物及其制备方法 | |
CN103784638A (zh) | 一种防治小儿热哮的中药汤剂 | |
CN106619741A (zh) | 一种用于治疗湿疹的药物及其制备方法 | |
CN105343332A (zh) | 茵陈虎杖复方药膏剂及其制备方法 | |
CN105687021A (zh) | 防治脚癣的爽足粉 | |
CN106727724A (zh) | 一种用于治疗皮肤瘙痒的药物及其制备方法 | |
CN106729598A (zh) | 一种用于皮肤瘙痒的药物组合物 | |
CN102274250B (zh) | 一种治疗肺结核的外贴中药及其制作方法 | |
CN105536028A (zh) | 促进皮肤创面修复的敷料及制备方法 | |
CN104971312A (zh) | 一种专治牛皮癣的外用药物 | |
CN104474407A (zh) | 一种治疗百日咳的中药制剂 | |
CN100352449C (zh) | 一种治疗脚癣和体癣的药物组合物及其制备方法 | |
CN104667242A (zh) | 一种治疗甲型h1n1流感的胶囊及其制备方法 | |
CN102441100A (zh) | 小儿咳喘药贴 | |
CN110384744A (zh) | 一种治疗皮肤炎症促进伤口愈合的组合物及制备方法 | |
CN106581653A (zh) | 一种治疗精神分裂症的药物组合物 | |
CN106668044A (zh) | 一种治疗慢性支气管炎的西药组合物 | |
CN1240378C (zh) | 除湿去骨痛外用制剂及其制备方法 | |
CN1315522C (zh) | 治疗肺结核的药物及其生产方法 | |
Xu et al. | Clinical observation on acupuncture plus acupoint sticking for bronchial asthma in remissive state | |
CN104189724B (zh) | 一种治疗喉部息肉的中药及制备方法 | |
CN105596462A (zh) | 一种治疗泌尿系统感染的中药制剂及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170315 |
|
WW01 | Invention patent application withdrawn after publication |